This report aims to provide a comprehensive presentation of the global market for Glial Cell Line Derived Neurotrophic Factor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glial Cell Line Derived Neurotrophic Factor. This report contains market size and forecasts of Glial Cell Line Derived Neurotrophic Factor in global, including the following market information:
Global Glial Cell Line Derived Neurotrophic Factor Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Glial Cell Line Derived Neurotrophic Factor market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
GSK-812 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Glial Cell Line Derived Neurotrophic Factor include GlaxoSmithKline Plc, Treeway BV and UniQure NV, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Glial Cell Line Derived Neurotrophic Factor companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Glial Cell Line Derived Neurotrophic Factor Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Glial Cell Line Derived Neurotrophic Factor Market Segment Percentages, by Type, 2022 (%)
GSK-812
LAUR-301
TW-002
AMT-090
Others
Global Glial Cell Line Derived Neurotrophic Factor Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Glial Cell Line Derived Neurotrophic Factor Market Segment Percentages, by Application, 2022 (%)
Amyotrophic Lateral Sclerosis
Brain Ischemia
Parkinson's Disease
Retinal Degeneration
Others
Global Glial Cell Line Derived Neurotrophic Factor Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Glial Cell Line Derived Neurotrophic Factor Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Glial Cell Line Derived Neurotrophic Factor revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Glial Cell Line Derived Neurotrophic Factor revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline Plc
Treeway BV
UniQure NV
Outline of Major Chapters:
Chapter 1: Introduces the definition of Glial Cell Line Derived Neurotrophic Factor, market overview.
Chapter 2: Global Glial Cell Line Derived Neurotrophic Factor market size in revenue.
Chapter 3: Detailed analysis of Glial Cell Line Derived Neurotrophic Factor company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Glial Cell Line Derived Neurotrophic Factor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Glial Cell Line Derived Neurotrophic Factor Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Glial Cell Line Derived Neurotrophic Factor Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Glial Cell Line Derived Neurotrophic Factor Overall Market Size
2.1 Global Glial Cell Line Derived Neurotrophic Factor Market Size: 2022 VS 2030
2.2 Global Glial Cell Line Derived Neurotrophic Factor Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Glial Cell Line Derived Neurotrophic Factor Players in Global Market
3.2 Top Global Glial Cell Line Derived Neurotrophic Factor Companies Ranked by Revenue
3.3 Global Glial Cell Line Derived Neurotrophic Factor Revenue by Companies
3.4 Top 3 and Top 5 Glial Cell Line Derived Neurotrophic Factor Companies in Global Market, by Revenue in 2022
3.5 Global Companies Glial Cell Line Derived Neurotrophic Factor Product Type
3.6 Tier 1, Tier 2 and Tier 3 Glial Cell Line Derived Neurotrophic Factor Players in Global Market
3.6.1 List of Global Tier 1 Glial Cell Line Derived Neurotrophic Factor Companies
3.6.2 List of Global Tier 2 and Tier 3 Glial Cell Line Derived Neurotrophic Factor Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Glial Cell Line Derived Neurotrophic Factor Market Size Markets, 2022 & 2030
4.1.2 GSK-812
4.1.3 LAUR-301
4.1.4 TW-002
4.1.5 AMT-090
4.1.6 Others
4.2 By Type - Global Glial Cell Line Derived Neurotrophic Factor Revenue & Forecasts
4.2.1 By Type - Global Glial Cell Line Derived Neurotrophic Factor Revenue, 2018-2023
4.2.2 By Type - Global Glial Cell Line Derived Neurotrophic Factor Revenue, 2024-2030
4.2.3 By Type - Global Glial Cell Line Derived Neurotrophic Factor Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Glial Cell Line Derived Neurotrophic Factor Market Size, 2022 & 2030
5.1.2 Amyotrophic Lateral Sclerosis
5.1.3 Brain Ischemia
5.1.4 Parkinson's Disease
5.1.5 Retinal Degeneration
5.1.6 Others
5.2 By Application - Global Glial Cell Line Derived Neurotrophic Factor Revenue & Forecasts
5.2.1 By Application - Global Glial Cell Line Derived Neurotrophic Factor Revenue, 2018-2023
5.2.2 By Application - Global Glial Cell Line Derived Neurotrophic Factor Revenue, 2024-2030
5.2.3 By Application - Global Glial Cell Line Derived Neurotrophic Factor Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Glial Cell Line Derived Neurotrophic Factor Market Size, 2022 & 2030
6.2 By Region - Global Glial Cell Line Derived Neurotrophic Factor Revenue & Forecasts
6.2.1 By Region - Global Glial Cell Line Derived Neurotrophic Factor Revenue, 2018-2023
6.2.2 By Region - Global Glial Cell Line Derived Neurotrophic Factor Revenue, 2024-2030
6.2.3 By Region - Global Glial Cell Line Derived Neurotrophic Factor Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Glial Cell Line Derived Neurotrophic Factor Revenue, 2018-2030
6.3.2 US Glial Cell Line Derived Neurotrophic Factor Market Size, 2018-2030
6.3.3 Canada Glial Cell Line Derived Neurotrophic Factor Market Size, 2018-2030
6.3.4 Mexico Glial Cell Line Derived Neurotrophic Factor Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Glial Cell Line Derived Neurotrophic Factor Revenue, 2018-2030
6.4.2 Germany Glial Cell Line Derived Neurotrophic Factor Market Size, 2018-2030
6.4.3 France Glial Cell Line Derived Neurotrophic Factor Market Size, 2018-2030
6.4.4 U.K. Glial Cell Line Derived Neurotrophic Factor Market Size, 2018-2030
6.4.5 Italy Glial Cell Line Derived Neurotrophic Factor Market Size, 2018-2030
6.4.6 Russia Glial Cell Line Derived Neurotrophic Factor Market Size, 2018-2030
6.4.7 Nordic Countries Glial Cell Line Derived Neurotrophic Factor Market Size, 2018-2030
6.4.8 Benelux Glial Cell Line Derived Neurotrophic Factor Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Glial Cell Line Derived Neurotrophic Factor Revenue, 2018-2030
6.5.2 China Glial Cell Line Derived Neurotrophic Factor Market Size, 2018-2030
6.5.3 Japan Glial Cell Line Derived Neurotrophic Factor Market Size, 2018-2030
6.5.4 South Korea Glial Cell Line Derived Neurotrophic Factor Market Size, 2018-2030
6.5.5 Southeast Asia Glial Cell Line Derived Neurotrophic Factor Market Size, 2018-2030
6.5.6 India Glial Cell Line Derived Neurotrophic Factor Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Glial Cell Line Derived Neurotrophic Factor Revenue, 2018-2030
6.6.2 Brazil Glial Cell Line Derived Neurotrophic Factor Market Size, 2018-2030
6.6.3 Argentina Glial Cell Line Derived Neurotrophic Factor Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Glial Cell Line Derived Neurotrophic Factor Revenue, 2018-2030
6.7.2 Turkey Glial Cell Line Derived Neurotrophic Factor Market Size, 2018-2030
6.7.3 Israel Glial Cell Line Derived Neurotrophic Factor Market Size, 2018-2030
6.7.4 Saudi Arabia Glial Cell Line Derived Neurotrophic Factor Market Size, 2018-2030
6.7.5 UAE Glial Cell Line Derived Neurotrophic Factor Market Size, 2018-2030
7 Glial Cell Line Derived Neurotrophic Factor Companies Profiles
7.1 GlaxoSmithKline Plc
7.1.1 GlaxoSmithKline Plc Company Summary
7.1.2 GlaxoSmithKline Plc Business Overview
7.1.3 GlaxoSmithKline Plc Glial Cell Line Derived Neurotrophic Factor Major Product Offerings
7.1.4 GlaxoSmithKline Plc Glial Cell Line Derived Neurotrophic Factor Revenue in Global Market (2018-2023)
7.1.5 GlaxoSmithKline Plc Key News & Latest Developments
7.2 Treeway BV
7.2.1 Treeway BV Company Summary
7.2.2 Treeway BV Business Overview
7.2.3 Treeway BV Glial Cell Line Derived Neurotrophic Factor Major Product Offerings
7.2.4 Treeway BV Glial Cell Line Derived Neurotrophic Factor Revenue in Global Market (2018-2023)
7.2.5 Treeway BV Key News & Latest Developments
7.3 UniQure NV
7.3.1 UniQure NV Company Summary
7.3.2 UniQure NV Business Overview
7.3.3 UniQure NV Glial Cell Line Derived Neurotrophic Factor Major Product Offerings
7.3.4 UniQure NV Glial Cell Line Derived Neurotrophic Factor Revenue in Global Market (2018-2023)
7.3.5 UniQure NV Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Glial Cell Line Derived Neurotrophic Factor Market Opportunities & Trends in Global Market
Table 2. Glial Cell Line Derived Neurotrophic Factor Market Drivers in Global Market
Table 3. Glial Cell Line Derived Neurotrophic Factor Market Restraints in Global Market
Table 4. Key Players of Glial Cell Line Derived Neurotrophic Factor in Global Market
Table 5. Top Glial Cell Line Derived Neurotrophic Factor Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Glial Cell Line Derived Neurotrophic Factor Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Glial Cell Line Derived Neurotrophic Factor Revenue Share by Companies, 2018-2023
Table 8. Global Companies Glial Cell Line Derived Neurotrophic Factor Product Type
Table 9. List of Global Tier 1 Glial Cell Line Derived Neurotrophic Factor Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Glial Cell Line Derived Neurotrophic Factor Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Glial Cell Line Derived Neurotrophic Factor Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Glial Cell Line Derived Neurotrophic Factor Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Glial Cell Line Derived Neurotrophic Factor Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Glial Cell Line Derived Neurotrophic Factor Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Glial Cell Line Derived Neurotrophic Factor Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Glial Cell Line Derived Neurotrophic Factor Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2024-2030
Table 30. GlaxoSmithKline Plc Company Summary
Table 31. GlaxoSmithKline Plc Glial Cell Line Derived Neurotrophic Factor Product Offerings
Table 32. GlaxoSmithKline Plc Glial Cell Line Derived Neurotrophic Factor Revenue (US$, Mn) & (2018-2023)
Table 33. GlaxoSmithKline Plc Key News & Latest Developments
Table 34. Treeway BV Company Summary
Table 35. Treeway BV Glial Cell Line Derived Neurotrophic Factor Product Offerings
Table 36. Treeway BV Glial Cell Line Derived Neurotrophic Factor Revenue (US$, Mn) & (2018-2023)
Table 37. Treeway BV Key News & Latest Developments
Table 38. UniQure NV Company Summary
Table 39. UniQure NV Glial Cell Line Derived Neurotrophic Factor Product Offerings
Table 40. UniQure NV Glial Cell Line Derived Neurotrophic Factor Revenue (US$, Mn) & (2018-2023)
Table 41. UniQure NV Key News & Latest Developments
List of Figures
Figure 1. Glial Cell Line Derived Neurotrophic Factor Segment by Type in 2022
Figure 2. Glial Cell Line Derived Neurotrophic Factor Segment by Application in 2022
Figure 3. Global Glial Cell Line Derived Neurotrophic Factor Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Glial Cell Line Derived Neurotrophic Factor Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Glial Cell Line Derived Neurotrophic Factor Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Glial Cell Line Derived Neurotrophic Factor Revenue in 2022
Figure 8. By Type - Global Glial Cell Line Derived Neurotrophic Factor Revenue Market Share, 2018-2030
Figure 9. By Application - Global Glial Cell Line Derived Neurotrophic Factor Revenue Market Share, 2018-2030
Figure 10. By Type - Global Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Glial Cell Line Derived Neurotrophic Factor Revenue Market Share, 2018-2030
Figure 12. By Application - Global Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Glial Cell Line Derived Neurotrophic Factor Revenue Market Share, 2018-2030
Figure 14. By Region - Global Glial Cell Line Derived Neurotrophic Factor Revenue Market Share, 2018-2030
Figure 15. By Country - North America Glial Cell Line Derived Neurotrophic Factor Revenue Market Share, 2018-2030
Figure 16. US Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Glial Cell Line Derived Neurotrophic Factor Revenue Market Share, 2018-2030
Figure 20. Germany Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2018-2030
Figure 21. France Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Glial Cell Line Derived Neurotrophic Factor Revenue Market Share, 2018-2030
Figure 28. China Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2018-2030
Figure 32. India Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Glial Cell Line Derived Neurotrophic Factor Revenue Market Share, 2018-2030
Figure 34. Brazil Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Glial Cell Line Derived Neurotrophic Factor Revenue Market Share, 2018-2030
Figure 37. Turkey Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Glial Cell Line Derived Neurotrophic Factor Revenue, (US$, Mn), 2018-2030
Figure 41. GlaxoSmithKline Plc Glial Cell Line Derived Neurotrophic Factor Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Treeway BV Glial Cell Line Derived Neurotrophic Factor Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. UniQure NV Glial Cell Line Derived Neurotrophic Factor Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
